mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.06 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.07 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.07 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.07 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.07 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |